Fortress Biotech Inc 9.375% Series A Cumulativ (FBIOP) Stock Price, Quote & News

Company Profile

Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products. The company markets dermatology products, including Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe recalcitrant nodular acne; Amzeeq, a topical formulation of minocycline for inflammatory lesions of non-n...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 652 4500

Website: www.fortressbiotech.com

Address:

1111 Kane Concourse, Suite 301, Bay Harbor Islands, United States

Chaka1647 May. 13 at 1:20 PM

Should be an interesting 24 hours for $FBIO and $FBIOP Keep in mind that I don't think they need to catch up on the dividend until before they publish the 10k (March 27) if they want the ability to raise under the shelf next year. I think if you are just worried about that ... you collect the interest on your cash and pay out later. But if you are worried about $FBIO apprecation being held back by lack of divys, you reinstate now

0 · Reply

Chaka1647 May. 8 at 3:52 PM

Feel free to due your own math, but this is the answer if you you ask Gemini what $FBIOP should be valued at if there is an 80% chance that dividend gets restored in 28 and 20% chance it is zero I obviously think scenario is much better than above. But it is so clear that $FBIOP is very undervalued per its prospects. But who the hell knows what happens in the short term.

2 · Reply

FinSUN May. 7 at 9:27 PM

$FBIO now, thanks to this breather bounce, we can move this back to $2, $FBIOP to $11.

3 · Reply

makrodimutross May. 7 at 4:00 PM

$FBIOP $FBIO Someone just dumped 15,617 FBIOP into the bid at 13.50. Wasn't intersted in waiting for LR any longer.

4 · Reply

makrodimutross May. 7 at 3:41 PM

$FBIO $FBIOP I did not watch the conference, but whatever was said had obviously a very minimal effect on the bid today. I find it fascinating to watch individual companies in the biotech sector compare to the XBI. FBIO seems to get hammered by negative sector sentiment, but barely moves upwards with positive sector sentiment. Major sign of fragility... which would be removed if only they made good on the arrears to FBIOP.

0 · Reply

FinSUN May. 6 at 2:04 PM

$FBIO $FBIOP

0 · Reply

BillionerOfKing May. 5 at 11:04 AM

$FBIOP Current Stock Price: $14.07

0 · Reply

deembi May. 5 at 8:00 AM

$FBIO $FBIOP Updated math based on last closing price of $14.08… Accumulated interest upon interest reinstatement: 31.89% ($4.49 on $14.08) Potential capital appreciation on residual value: 160.69% ($9.59 → $25) Ongoing annual yield: ~24.50% (=$2.35 on $9.59) Equity or Preferred. - what makes sense?

2 · Reply

Chaka1647 May. 3 at 4:05 PM

$FBIOP $FBIO Looks like we lost zellchair again?

5 · Reply

makrodimutross May. 1 at 7:41 PM

$FBIOP this is how i feel about FBIOP

1 · Reply

Market Cap	N/A
Revenue (ttm)	84.51M
Net Income (ttm)	-60.64M
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	304
Avg Vol	18,892
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	79%
Beta	N/A
Analysts	Strong Buy
Price Target	N/A